65 resultados para Antirheumatic Drug Trials
em Institute of Public Health in Ireland, Ireland
Resumo:
��In a sign that researchers are grappling with therapy development, the 4th annual conference on Clinical Trials in Alzheimer's Disease was filled beyond its venue's capacity, drawing 522 researchers from around the globe. Held 3-5 November 2011 in San Diego, CTAD is the brainchild of Paul Aisen, Jacques Touchon, Bruno Vellas, and Michael Weiner. The conference posted no ringing trial successes. Instead, scientists worked on methodological aspects they hope will improve future trials' chances. They discussed Bayesian models, simulated placebos, and biomarker data standards. They presented alternative outcome measures to the ADAS-cog, ranging widely from composite scales that are sensitive early on to continuous measures that encompass a patients' day-to-day variability. They focused on EEG, and on a collective effort to develop patient-reported outcomes. Highlights include:Whence and Where To: History and Future of AD Therapy Trials��Webinar: Evolution of AD Trials��Nutrient Formulation Appears to Grease Memory Function��Door Slams on RAGE��Clinical Trials: Making "Protocols From Hell" Less Burdensome��EEG: Coming in From the Margins of Alzheimer's Research?��EEG: Old Method to Lend New Help in AD Drug Development?������
Resumo:
PAS Alerts 2011 to 2012
Resumo:
Health and Personal Social Services for Northern Ireland Drug Tariff
Resumo:
2007-2008
Resumo:
2009-2010
Resumo:
Pre Release Access list for Bulletin 5 Drug Prevalence Survey 2006/07
Resumo:
Summary of the findings for 2005/06 from the four collaborating centres in Northen Ireland
Resumo:
Survey of Injecting Drug Users: Summary of the findings for 2004/05 from the four collaborating centres in Northern Ireland
Resumo:
Shooting Up: Infections among injecting drug users in the United Kingdom - Northern Ireland Summary
Resumo:
Summary of the findings for 2003/04 in Northern Ireland
Resumo:
Census of Drug and Alcohol Treatment Services in Northern Ireland: 1 March 2005
Resumo:
Guidance on Drug and Substance Misuse in Mental Health Care Settings